The peptide hormone is detectable in the CSF for at least 80 min, and less than 3% of the administered insulin reaches the systemic bloodstream without causing systemic hypoglycemia or hepatic first-pass metabolism [33]. The gene discussed is INS; the disease is Hypoglycemia.